Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_provenance.
- NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_assertion description "[Stromal cells, derived from bone marrow or lymph nodes, and B cells from follicular lymphoma patients were cocultured or cultured alone with celecoxib treatment, a nonsteroidal anti-inflammatory drug, and/or TRAIL, a promising cytotoxic molecule for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_provenance.
- NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_assertion evidence source_evidence_literature NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_provenance.
- NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_assertion SIO_000772 24637636 NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_provenance.
- NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_assertion wasDerivedFrom befree-20150227 NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_provenance.
- NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_assertion wasGeneratedBy ECO_0000203 NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_provenance.
- befree-20150227 importedOn "2015-02-27" NP803725.RAXSCin6j46n_GV64-D-J9vmUoe1pV1-G82B2TpgIOr2M130_provenance.